A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells. - Augello G; Puleio R; Emma MR; Cusimano A; Loria GR; McCubrey JA; Montalto G; Cervello M (Cell cycle (Georgetown, Tex.), 2016)